Dexrazoxane Role in the Prevention of Anthracycline Cardiotoxicity in Sarcoma Patients - A Meta-analysis

被引：0
|
作者：
Sousa, Josac P.
Teixeira, Rogerio
Lourenco, Carolina
Goncalves, Lino
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16119
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism
    B. J. Cusack
    H. Gambliel
    B. Musser
    N. Hadjokas
    S. E. Shadle
    H. Charlier
    R. D. Olson
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 517 - 526
  • [22] Cardiac biomarkers for the detection of anthracycline cardiotoxicity in childhood cancer - a meta-analysis
    Michel, L.
    Mincu, R. I.
    Mrotzek, S. M.
    Neudorf, U.
    Rassaf, T.
    Totzeck, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 300 - 300
  • [23] Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation
    Jirkovsky, Eduard
    Jirkovska, Anna
    Bavlovic-Piskackova, Hana
    Skalicka, Veronika
    Pokorna, Zuzana
    Karabanovich, Galina
    Kollarova-Brazdova, Petra
    Kubes, Jan
    Lencova-Popelova, Olga
    Mazurova, Yvona
    Adamcova, Michaela
    Lyon, Alexander R.
    Roh, Jaroslav
    Simunek, Tomas
    Sterbova-Kovarikova, Petra
    Sterba, Martin
    CIRCULATION-HEART FAILURE, 2021, 14 (11) : E008209
  • [24] Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
    Kalam, Kashif
    Marwick, Thomas H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2900 - 2909
  • [25] Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
    Ma, Yingxu
    Bai, Fan
    Qin, Fen
    Li, Jiayi
    Liu, Na
    Li, Dongping
    Li, Tengfang
    Xie, Hui
    Liu, Da
    Zhou, Shenghua
    Liu, Qiming
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [26] Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
    Yingxu Ma
    Fan Bai
    Fen Qin
    Jiayi Li
    Na Liu
    Dongping Li
    Tengfang Li
    Hui Xie
    Da Liu
    Shenghua Zhou
    Qiming Liu
    BMC Pharmacology and Toxicology, 20
  • [27] Efficacy of SGLT2 inhibitors for anthracycline-induced cardiotoxicity: a meta-analysis in cancer patients
    Mohsin, Sana
    Hasan, Misha
    Sheikh, Zubaid Moazzam
    Mustafa, Fatima
    Tegeltija, Vesna
    Kumar, Sarwan
    Kumar, Jai
    FUTURE CARDIOLOGY, 2024, 20 (7-8) : 395 - 407
  • [28] Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials
    D'Amario, Domenico
    Laborante, Renzo
    Bianchini, Emiliano
    Galli, Mattia
    Ciliberti, Giuseppe
    Mennuni, Marco
    Patti, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 391
  • [29] Systematic review and meta-analysis of definitions and reported incidences of anthracycline cardiotoxicity.
    Jang, Sae
    Ruddy, Kathryn Jean
    Loprinzi, Charles L.
    Armenian, Saro
    Lenihan, Daniel John
    Herrmann, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Role of cardioprotective therapies for prevention of cardiotoxicity in breast cancer: A systematic review and meta-analysis
    Kong, Y. C.
    Sener, M.
    Subramaniam, S.
    Bhoo-Pathy, N.
    ANNALS OF ONCOLOGY, 2019, 30
12345